HFX for PDN: A Nondrug Solution for Painful Diabetic Neuropathy with Niamh Pellegrini and Meredith Vornholt of Nevro
In this episode, we are privileged to host two outstanding healthcare leaders that can help us learn a new way of managing diabetic neuropathy. Niamh Pellegrini is the Chief Commercial Officer at Nevro, and Meredith Vornholt is the Senior Director of PDN Marketing.
Niamh and Meredith discuss HFX for PDN and how it can help patients suffering from diabetic neuropathy. They share insights on leveraging technology to help patient care, employer impact, challenges, patient anecdotes, and many more.
This HFX for PDN is the only spinal cord simulation approved by the FDA for manage pains associated with diabetic neuropathy.
Learn more about this innovative treatment in this exciting episode of the Outcomes Rocket podcast, so please tune in!
Click this link to the show notes, transcript, and resources: outcomesrocket.health